手机版 English 帮助中心
外文文献知网节
文献信息节点
基本信息 摘要 关键词 核心评价 相关文献
Journal | [J] 临床医学研究 Volume 4, Issue 6. 2022.
化疗和信号传导
作者 : 泰季 亚娜, 伊利 亚·, 埃里 卡·, 伊戈 尔·
DOI: 10.12361/2705-0939-04-06-98094
全部来源
获取全文
摘要 / Abstract
近年来，肿瘤学家已经开始得出结论，即使毒性可以得到有效控制，化疗作为主要治疗方式的疗效也已达 到平台期。新兴的信号通路和代谢通路特异性抑制剂（即靶向药物）与传统化疗药物相比，后者主要干扰DNA生物 合成和细胞复制机制。为了提高疗效，靶向药物与常规化疗药物的组合已成为在早期临床试验中测试多种新药的常 规方法。这篇综述讨论了最近的进展，包括综合系统生物学和RNAi方法来抵消化疗耐药性并支持抗癌药物治疗的 选择性、疗效和个性化。
关键词 / Keywords
化学疗法；耐药性；靶向治疗；RNAi筛选；综合生物学；DNA损伤；合成杀伤力
Related articles / 相关文献
相似文献
作者发文
机构发文
关键词分析
相似文献（说明：与本文内容较接近的文献）
  • [1]Gilman A, Philips FS. The biological actions and
  • therapeutic applications of the B-chloroethyl amines and
  • sulfides. Science. 1946;103:409–436.
  • [2]Tallman MS, Gray R, Robert NJ, LeMaistre CF,
  • Osborne CK, Vaughan WP, et al. Conventional adjuvant
  • chemotherapy with or without high-dose chemotherapy and
  • autologous stem-cell transplantation in high-risk breast
  • cancer. N Engl J Med. 2003;349:17–26.
  • [3]Stadtmauer EA, O'Neill A, Goldstein LJ, Crilley PA,
  • Mangan KF, Ingle JN, et al. Conventional-dose chemotherapy
  • compared with high-dose chemotherapy plus autologous
  • hematopoietic stem-cell transplantation for metastatic breast
  • cancer. Philadelphia Bone Marrow Transplant Group. N Engl J
  • Med. 2000;342:1069–1076.
  • [4]Cobo M, Isla D, Massuti B, Montes A, Sanchez JM,
  • Provencio M, et al. Customizing cisplatin based on quantitative
  • excision repair cross-complementing 1 mRNA expression: a
  • phase III trial in non-small-cell lung cancer. J Clin Oncol.
  • 2007;25:2747–2754.
  • [5]Cohen P. The development and therapeutic potential of
  • protein kinase inhibitors. Curr Opin Chem Biol. 1999;3:459–
  • 465.
  • [6]NOWELL PC, HUNGERFORD DA. Chromosome
  • studies on normal and leukemic human leukocytes. J Natl
  • Cancer Inst. 1960 Jul;25:85-109.
  • [7]Huggins C, Hodges CV. Studies on prostatic cancer. I.
  • The effect of castration, of estrogen and androgen injection on
  • serum phosphatases in metastatic carcinoma of the prostate.
  • CA Cancer J Clin. 1972 Jul-Aug;22(4):232-40.
  • [8]Fisher B, Costantino JP, Wickerham DL, Redmond
  • CK, Kavanah M, Cronin WM, Vogel V, Robidoux A, Dimitrov
  • N, Atkins J, Daly M, Wieand S, Tan-Chiu E, Ford L, Wolmark
  • N. Tamoxifen for prevention of breast cancer: report of the
  • National Surgical Adjuvant Breast and Bowel Project P-1
  • Study. J Natl Cancer Inst. 1998 Sep 16;90(18):1371-88.
  • [9]Baum M, Brinkley DM, Dossett JA, McPherson K,
  • Patterson JS, Rubens RD, Smiddy FG, Stoll BA, Wilson A, Lea
  • JC, Richards D, Ellis SH. Improved survival among patients
  • treated with adjuvant tamoxifen after mastectomy for early
  • breast cancer. Lancet. 1983 Aug 20;2(8347):450.
  • [10]McLaughlin P, Grillo-López AJ, Link BK, Levy R,
  • Czuczman MS, Williams ME, Heyman MR, Bence-Bruckler I,
  • White CA, Cabanillas F, Jain V, Ho AD, Lister J, Wey K, Shen
  • D, Dallaire BK. Rituximab chimeric anti-CD20 monoclonal
  • antibody therapy for relapsed indolent lymphoma: half of
  • patients respond to a four-dose treatment program. J Clin
  • Oncol. 1998 Aug;16(8):2825-33.
《中国学术期刊(光盘版)》电子杂志社有限公司 KDN平台基础技术由KBASE 11.0提供
© 2014-2018中国知网(CNKI) 京公网安备11010802020460号 经营性网站备案信息 互联网出版许可证 新出网证(京)字271号 京ICP证040431号